InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
T+90 hit rate
0%
T+90 mean return
-52.6%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Jung Cassie, Chief Operating Officer. Insider active across 1 company, notably Aquestive Therapeutics, Inc.. In total, 8 filings have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €205. History available since 9 March 2023. The latest transaction was disclosed on 15 October 2025 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations8 total
25,000 shares@ US$3.102750.0% of flowCommon StockSEC:0001214659-25-015048
25,000 shares@ US$3.10270.0085% mcap50.0% of flowCommon StockSEC:0001214659-25-015048:0
80,000 shares0Common StockSEC:0001214659-25-004227:0
44 shares@ US$4.8650.1% of flowCommon StockSEC:0001214659-24-019685:0
14,120 shares@ US$4.8827.0% of flowCommon StockSEC:0001214659-24-017008:0
8,300 shares@ US$4.8815.9% of flowCommon StockSEC:0001214659-24-004390:0
1,365 shares0Common StockSEC:0001214659-24-004304:0
110,000 shares0Common StockSEC:0001214659-23-003693:0
8 of 8 declarations
About Jung Cassie
Cassie Jung is the Chief Operating Officer at Aquestive Therapeutics, Inc. She oversees the daily operations of the company, focusing on efficiency and innovation. Her role is essential for ensuring performance and growth at Aquestive.
